TABLE 4.
Univariate analysis of the correlation between cognition and benzodiazepines.
| BZDs use (n = 30) | Non-BZDs use (n = 90) | P-value | |
| MMSE scores | 26.00 (23.00, 28.00) | 28.00 (26.00, 28.25) | 0.013 |
| MoCA scores | 21.20 ± 3.49 | 23.50 ± 3.65 | 0.003 |
| Long-term delayed recall of AVLT scores | 5.00 (4.00, 6.00) | 7.00 (3.75, 9.75) | 0.184 |
| TMT-B scores | 126.00 (81.00, 300.00) | 85.00 (57.75, 217.00) | 0.062 |
| BNT-30 scores | 25.80 ± 3.02 | 25.42 ± 3.30 | 0.581 |
| CDT scores | 4.00 (3.00, 4.00) | 4.00 (3.00, 4.00) | 0.596 |
| DST scores | 4.00 (3.00, 5.00) | 5.00 (4.00, 5.25) | 0.004 |
| HAMD scores | 10.00 (6.00, 13.00) | 9.00 (6.75, 11.50) | 0.766 |
| HAMA scores | 10.00 (6.00, 12.00) | 9.00 (7.00, 15.25) | 0.808 |
| Male | 12 (20.83%) | 27 (20.83%) | 0.311 |
| Age (years) | 64.20 ± 6.98 | 59.22 ± 5.52 | 0.000 |
| Married/cohabitating | 24 (80.00%) | 85 (94.44%) | 0.045 |
| Living with others | 24 (80.00%) | 87 (96.67%) | 0.009 |
| Low income | 18 (60.00%) | 46 (51.11%) | 0.398 |
| Education (years) | 11.27 ± 3.63 | 11.75 ± 3.37 | 0.505 |
| BMI, kg/m2 | 22.95 ± 2.55 | 23.63 ± 2.86 | 0.247 |
| Smoking, % | 4 (13.33%) | 19 (21.11%) | 0.349 |
| Concomitant illness | |||
| Hypertension, % | 16 (53.33%) | 22 (24.44%) | 0.003 |
| Diabetes mellitus, % | 6 (20.00%) | 11 (12.22%) | 0.450 |
| Coronary heart disease, % | 4 (13.33%) | 8 (8.89%) | 0.725 |
| Dyslipidemia, % | 8 (26.67%) | 39 (43.33%) | 0.105 |
| Gout, % | 2 (6.67%) | 2 (2.22%) | 0.557 |
| Insomnia | |||
| Age at onset (years) | 50.00 (28.00, 58.00) | 48.00 (42.25, 54.25) | 0.872 |
| Insomnia duration (years) | 17.00 (5.00, 34.00) | 10.00 (3.00, 15.25) | 0.214 |
| PSQI scores | 14.27 ± 3.05 | 13.90 ± 2.71 | 0.535 |